To compare the therapeutic effect of Lycopodium clavatum 30 and Individualised Homoeopathic Medicine to reduce the symptoms and diagnostic findings in individuals with Urolithiasis

A comparative evaluation of the therapeutic effect of Lycopodium clavatum 30 and Individualised Homoeopathic Medicine in the management of Urolithiasis - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106793

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Lycopodium 30: Study arm A will be given given Lycopodium 30 ( 3 pills 3 times daily ) for a period of 2 weeks, reviewed at 15 days interval. Treatment effectiveness will be evaluated f

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnosed cases of Urolithiasis (by Ultrasound scan of Whole Abdomen) 2)age group 20- 60 years of both sexes 3)stone size up to 8 mm 4)Those who have given consent for the study

Exclusion criteria

Exclusion criteria: 1)Cases with severe hydronephrosis 2)Cases with renal failure 3)Cases with Pyelonephritis 4)Patients with other comorbidities like Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
To evaluate the therapeutic effect of Lycopodium clavatum 30 and Individualised Homoeopathic Medicine in reducing the symptoms and diagnostic findings in patients with Urolithiasis by assessing Ultrasound scan of Whole Abdomen and Urolithiasis Symptom Score (USS).Timepoint: Treatment effectiveness will be evaluated from the baseline to the end of 3 months, taking into account in the reduction of the symptoms and diagnostic findings in patients with urolithiasis determined by Ultrasound scan of Whole Abdomen and the patients improved symptomatic state is determined by Urolithiasis symptom score( at the end of 3 month)	—

Measure

Time frame

To evaluate the therapeutic effect of Lycopodium clavatum 30 and Individualised Homoeopathic Medicine in reducing the symptoms and diagnostic findings in patients with Urolithiasis by assessing Ultrasound scan of Whole Abdomen and Urolithiasis Symptom Score (USS).Timepoint: Treatment effectiveness will be evaluated from the baseline to the end of 3 months, taking into account in the reduction of the symptoms and diagnostic findings in patients with urolithiasis determined by Ultrasound scan of Whole Abdomen and the patients improved symptomatic state is determined by Urolithiasis symptom score( at the end of 3 month)

—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Satheesh G

drsatheeshg1967@gmail.com9447263693

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026